How does this have to do with GLP-1s
The Origin and Understanding of the Incretin Concept
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
101 Albiglutide Albiglutide was approved by the FDA in 2014
Our 24 mg astaxanthin supplements, verified by third-party testing, offer numerous benefits, providing excellent value and quality you can trust